Biogen Inc.
0
0
0%

Financials

Income statement

Fiscal date 2024 2023 2022 2021
Total reported revenue 9.7B 9.8B 10.2B 11.0B
Cost of revenue 2.3B 2.5B 2.3B 2.1B
Gross profit 7.4B 7.3B 7.9B 8.9B
Operating expense
Research & development 2.0B 2.5B 2.2B 2.5B
Selling general and admin 2.4B 2.5B 2.4B 2.7B
Other operating expenses 254.4M 218.8M -7.4M 7.2M
Operating income 2.2B 1.8B 2.9B 2.8B
Non operating interest income
Income 67.6M 276.5M 89.3M 11M
Expense 250.3M 246.9M 246.6M 253.6M
Other income expense -130.2M -563.9M 847.2M -820.2M
Pretax income 1.9B 1.3B 3.6B 1.7B
Tax provision 273.8M 135.3M 632.8M 52.5M
Net income 1.6B 1.2B 3.0B 1.7B
Basic EPS 11.2 8.0 21.0 10.4
Diluted EPS 11.2 8.0 20.9 10.4
Basic average shares 145.6M 144.7M 145.3M 149.1M
Diluted average shares 145.6M 144.7M 145.3M 149.1M
EBITDA 3.0B 2.6B 3.5B 3.7B
Net income from continuing op. 1.6B 1.2B 3.0B 1.7B
Minority interests 0 -400K 85.3M -171.5M
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 49 minutes

15:10
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Main market
09:30 - 16:00
All times are displayed in the America/Santiago timezone (-03, UTC-03:00).